GSK-3 Inhibitors

GSK-3

GSK-3α

GSK-3β

GSK-3 Degraders & Inhibitors

Product Name	GSK-3	GSK-3α	GSK-3β	Purity
Laduviglusib		GSK-3α, IC₅₀: 10 nM	GSK-3β, IC₅₀: 6.7 nM	99.76%
SB 216763		GSK-3α, IC₅₀: 34.3 nM	GSK-3β, IC₅₀: 34.3 nM	99.82%
Kenpaullone			GSK-3β, IC₅₀: 0.023 μM	98.16%
LY2090314		GSK-3α, IC₅₀: 1.5 nM	GSK-3β, IC₅₀: 0.9 nM	99.78%
Laduviglusib monohydrochloride		GSK-3α, IC₅₀: 10 nM	GSK-3β, IC₅₀: 6.7 nM	99.93%
GSK 3 Inhibitor IX		GSK-3α, IC₅₀: 5 nM	GSK-3β, IC₅₀: 5 nM	99.74%
Laduviglusib trihydrochloride		GSK-3α, IC₅₀: 10 nM	GSK-3β, IC₅₀: 6.7 nM	99.35%
TWS119			GSK-3β, IC₅₀: 30 nM	99.20%
Tideglusib			GSK-3β(WT), IC₅₀: 5 nM GSK-3β(C199A), IC₅₀: 60 nM	99.79%
AR-A014418			GSK-3β, IC₅₀: 104 nM	99.14%
1-Azakenpaullone			GSK-3β, IC₅₀: 18 nM	99.61%
Cromolyn sodium			GSK-3β, IC₅₀: 2 μM	99.93%
IM-12			GSK-3β, IC₅₀: 53 nM	99.61%
AZD1080		GSK-3α, pKi: 8.2	GSK-3β, pKi: 7.5	99.46%
TDZD-8			GSK-3β, IC₅₀: 2 μM	99.81%
CHIR-98014		GSK-3α, IC₅₀: 0.65 nM	GSK-3β, IC₅₀: 0.58 nM	≥98.0%
AZD2858		GSK-3α, IC₅₀: 0.9 nM	GSK-3β, IC₅₀: 5 nM	98.42%
9-ING-41			GSK-3β, IC₅₀: 0.71 μM	98.83%
R547		GSK-3α, IC₅₀: 46 nM	GSK-3β, IC₅₀: 260 nM	99.57%
Lithium chloride hydrate			GSK-3β
CP21R7			GSK-3β, IC₅₀: 1.8 nM	99.63%
SB 415286		hGSK-3α, IC₅₀: 77.5 nM	hGSK-3β, IC₅₀: 77.5 nM	99.57%
Indirubin-3'-monoxime			GSK-3β, IC₅₀: 22 nM	99.89%
Laduviglusib (GMP)		GSK-3α, IC₅₀: 10 nM	GSK-3β, IC₅₀: 6.7 nM
RGB-286638			GSK-3β, IC₅₀: 3 nM	99.84%
KY19382			GSK3β, IC₅₀: 10 nM	≥98.0%
BRD0705		GSK3α, IC₅₀: 66 nM GSK3α, Kd: 4.8 μM	GSK-3β(WT), IC₅₀: 515 nM	99.80%
Bikinin	GSK-3			99.96%
BRD3731		GSK-3α, IC₅₀: 215 nM	GSK-3β, IC₅₀: 15 nM	98.21%
EHT 5372		GSK-3α, IC₅₀: 7.44 nM	GSK-3β, IC₅₀: 221 nM	98.12%
SAR502250			hGSK-3β, IC₅₀: 12 nM	99.63%
BIO-acetoxime		GSK-3α, IC₅₀: 10 nM	GSK-3β, IC₅₀: 10 nM	≥98.0%
A 1070722		GSK-3α, Ki: 0.6 nM	GSK-3β, Ki: 0.6 nM	99.95%
PF-04802367		GSK-3α, IC₅₀: 10 nM	GSK-3β, IC₅₀: 9 nM	98.84%
GSK-3 inhibitor 1	GSK-3			99.89%
Cu(II)GTSM			GSK3β
K00546	GSK-3, IC₅₀: 140 nM			98.08%
Alsterpaullone		GSK-3α, IC₅₀: 4	GSK-3β, IC₅₀: 4 nM	98.38%
GSK-3β inhibitor 2			GSK-3β, IC₅₀: 1.1 nM
GSK-3β inhibitor 1			GSK-3β, IC₅₀: 4.9 nM	98.04%
Manzamine A hydrochloride			GSK-3β, IC₅₀: 10.2 μM	99.66%
TCS 21311			GSK-3β, IC₅₀: 3 nM	99.18%
GSK2646264			GSK3β, pIC₅₀: 5.3	98.39%
GSK-3 inhibitor 3		GSK-3α, IC₅₀: 0.35 nM	GSK-3β, IC₅₀: 0.25 nM	98.72%
7BIO			GSK3β	≥98.0%
GNF4877			GSK3β, IC₅₀: 16 nM	99.32%
MeBIO	GSK-3, IC₅₀: 44 μM			≥98.0%
Indirubin-3′-oxime			GSK-3β	99.49%
GSK-3β inhibitor 3			GSK-3β, IC₅₀: 6.6 μM	98.20%
CHIR 98024	GSK-3, EC₅₀: 0.2566 μM			98.08%
GSK3β inhibitor II			GSK-3β	99.76%
BIP-135		GSK-3α, IC₅₀: 16 nM	GSK-3β, IC₅₀: 21 nM	99.86%
RGB-286638 free base			GSK-3β, IC₅₀: 3 nM	98.07%
5-Iodo-indirubin-3'-monoxime			GSK-3β, IC₅₀: 9 nM	99.50%
Phospho-Glycogen Synthase Peptide-2(substrate) TFA	GSK-3			98.02%
(R)-BRD3731		GSK3α, IC₅₀: 6.7 μM	GSK3β, IC₅₀: 1.05 μM	98.22%
GSK-3β inhibitor 11			GSK-3β, IC₅₀: 10.02 μM	98.02%
(E/Z)-BIO-acetoxime		GSK-3α, IC₅₀: 10 nM	GSK-3β, IC₅₀: 10 nM
NSC693868			GSK-3β, IC₅₀: 1 μM
GSK-3β inhibitor 10			GSK-3β, IC₅₀: 80.5 nM	98.04%
hAChE-IN-6			GSK-3β, IC₅₀: 0.26 μM
Aloisine A		GSK-3α, IC₅₀: 1.5 μM	GSK-3β, IC₅₀: 0.5 μM
PROTAC GSK-3β Degrader-1			GSK-3β, IC₅₀: 833 nM
AChE/BACE1/GSK3β-IN-1			GSK-3β, IC₅₀: 15 μM
ZLWH-23			GSK-3β, IC₅₀: 6.78 μM
GSK-3β inhibitor 8			GSK-3β, IC₅₀: 64 nM
CDK8-IN-12		GSK-3α, Ki: 13 nM	GSK-3β, Ki: 4 nM
GSK-3β inhibitor 6			GSK-3β, IC₅₀: 24.4 μM
CDK7-IN-20			GSK3β, IC₅₀: 148 nM
2B-(SP)		GSK-3α	GSK-3β
CHIR-98023		GSK3α, IC₅₀: 10 nM	GSK3β, IC₅₀: 6.7 nM
2B-(SP) (TFA)		GSK-3α	GSK-3β
GSK-3β inhibitor 7			GSK-3β, IC₅₀: 5.25 μM
GSK-3 inhibitor 4		GSK-3α, IC₅₀: 0.45 nM	GSK-3β, IC₅₀: 0.56 nM
TC-G 24			GSK-3β, IC₅₀: 17.1 nM
Phospho-Glycogen Synthase Peptide-2(substrate)	GSK-3
Manzamine A			GSK-3β, IC₅₀: 10.2 μM
JNK3 inhibitor-5			GSK-3β, IC₅₀: 3889.7 nM
18BIOder			GSK-3β
Indirubin-3'-monoxime-5-sulphonic acid			GSK-3β, IC₅₀: 80 nM
Aloisine RP106	GSK-3, IC₅₀: 0.92 μM
ZDWX-25			GSK-3β, IC₅₀: 71 nM
GS87		GSK3α, IC₅₀: 415 nM	GSK3β, IC₅₀: 521 nM
GSK-3β inhibitor 13		GSK-3α, IC₅₀: 0.35 nM	GSK-3β, IC₅₀: 0.73 nM
TCS2002	GSK-3, IC₅₀: 35 nM

Name
Email *

	Sorry, but the email address you supplied was invalid.